drugset / Trial / NCT05203562
Letrozole as a Prophylaxis From GTN for Complete Mole Patients
RandomizedParallel-groupSingle-blindPrevention
Summary
Prophylactic use of aromatase inhibitor is effective in decreasing the incidence of Gestational Trophoblastic Neoplasia (GTN) in patients with complete hydatidiform mole (CHM)
Timeline
- Start
- 2020-06-01
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 5 mg | — |